VisMederi Holding
Improving human healthVisMederi Holding
VisMederi Holding is the company that holds a qualified share of the companies that are part of the VisMederi Group. The Group of VisMederi Holding operates in various business areas all related to Research and Innovation in the fields of Public Health, Life Sciences and Biotechnologies and is composed of VisMederi Srl, VisMederi Research Srl, VisMederi Life Sciences Srl, VisMederi Textyle Srl, VisMederi Pharma Srl, ETHS – Education and Training for Health Sciences Srl with single shareholder, Accurange Srl.
Revenues
Employees
Global Partnerships
Vismederi Holding: latest news
All the news of the group
VisMederi signs vaccine research partnership with GCCL at World Vaccine Congress 2026
Universal influenza vaccine candidate, collaboration with Sumitomo Pharma Co., Ltd. and Japan’s National Institutes of Biomedical Innovation Health and Nutrition (NIBN)
VisMederi is a partner in the EU-selected NOFLU consortium supporting early clinical development of a next-generation pandemic influenza vaccine
VisMederi steps up Nipah readiness as India reports a new signal in West Bengal.
VisMederi drives progress toward the 100 Days Mission through CEPI’s world-leading network
New scientific publication: “High-dose influenza vaccine: enhanced protection for the elderly”
VisMederi America: a new chapter in the Group’s international growth
VisMederi in the Sole 24 Ore ranking: recognized growth and international development
Development and Qualification of the Shigella Multiplex Assay: New Publication Highlights Major Collaborative Milestone
VisMederi contributes to Clover Biopharmaceuticals’ advancement in innovative respiratory combination vaccines
Where we
are
The
founder
Emanuele Montomoli is Full Professor of Hygiene and Public Health at the University of Siena, Italy. He received his BSc and MSc in Life Sciences from the University of Siena, Italy in 1997 and he earned his MBiochem in 2001.